88 Energy one step closer to Icewine-1 spud

|

Published 18-SEP-2015 11:50 A.M.

|

1 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

88 Energy (ASX:88E) has received one of three key pieces of regulatory approval prior to drilling the Icewine-1 well in Alaska – and the regulator is holding its application up as a sterling example.

The ASX-listed company told the market this morning that its ‘Lease Plan of Operations’ application to the Alaskan Department of Natural Resources (DNR) had been given the tick from the regulator.

The approval is one of three key pieces of approval needed before a mid-October spud of the Icewine-1 well, which is testing an unconventional oil play on the Alaskan North Slope.

What’s more, the DNR has asked 88E if it can use its application as an example on its website for other operators to follow.

It still needs to get the sign-off on an oil discharge plan and a final permit to drill, but 88E said it was confident these could be secured well before the well’s mid-October spud date.

About Icewine-1

The well is being drilled as a vertical hole, primarily targeting the ‘HRZ Shale’, a formation which the US Geological Survey thinks may hold as much as 2 billion barrels of oil and has been identified using the same method used to identify sweet spots of the Eagle Ford Shale.

Independent experts, Degolyer and MacNaughton are more conservative and believe the Company may have as much as 492 million barrels of oil on its hands (gross, prospective, unrisked).

It has a risked mean of 200.3MMbbls of oil, based on a 41% geological chance of success.

Previous drilling into the HRZ has shown porosity to be 18.4%, which is estimated to be about 50% better than the Eagle Ford Shale in Texas.

88E is also looking at conventional oil drilling due to be conducted by Great Bear Petroleum to the north in the next few months as a likely indicator of the conventional potential of the area.

tags

OIL


General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X